We are live on ! Find out more
MC

Miles Capital Portfolio holdings

AUM $92.8M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
-4.29%
3 Year Est. Return
+15.37%
5 Year Est. Return
+31.97%
10 Year Est. Return
AUM
$172M
AUM Growth
-$3.97M
Cap. Flow
-$9.29M
Cap. Flow %
-5.39%
Top 10 Hldgs %
47.22%
Holding
204
New
22
Increased
24
Reduced
107
Closed
18
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPPI
201
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-16,005
Closed -$225K
AJRD
202
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-11,443
Closed -$401K
AKS
203
DELISTED
AK Steel Holding Corp
AKS
-28,173
Closed -$157K
BOBE
204
DELISTED
Bob Evans Farms, Inc.
BOBE
-3,606
Closed -$280K

Similar funds

Miles Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Miles Capital held 204 positions worth $172M, down 2.3% from $176M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Miles Capital withdrew a net $9.29M in Q4 2017, closing 18 positions and reducing 107 holdings. Its most notable exit was Procter & Gamble, an estimated $478K position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9.6% a quarter earlier, followed by Technology and Energy.

Against the trend, Miles Capital opened a new position in State Street SPDR S&P Biotech ETF worth $809K.

  • Miles Capital's largest Q4 2017 buy was State Street SPDR S&P Biotech ETF: 9,533 shares worth $809K.
  • Miles Capital added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2017, an estimated $2.2M increase.
  • Miles Capital's biggest Q4 2017 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $11.1M.
  • Miles Capital fully exited Procter & Gamble in Q4 2017, selling an estimated $478K.
  • Miles Capital's ten largest holdings make up 47% of its $172M portfolio in Q4 2017.
  • Miles Capital opened 22 new positions and closed 18 in Q4 2017.
  • Miles Capital's portfolio value fell 2.3% quarter-over-quarter to $172M.

Based on Miles Capital's 13F filing for Q4 2017, filed 31 Jan 2018.